Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
1.135
-0.130 (-10.28%)
Jan 21, 2026, 2:48 PM CET
-67.76% (1Y)
| Market Cap | 38.45M |
| Revenue (ttm) | 36.23M |
| Net Income (ttm) | -25.78M |
| Shares Out | 30.40M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 266,414 |
| Average Volume | 89,699 |
| Open | 1.220 |
| Previous Close | 1.265 |
| Day's Range | 1.000 - 1.250 |
| 52-Week Range | 1.000 - 3.560 |
| Beta | 1.24 |
| RSI | 45.02 |
| Earnings Date | Jan 21, 2026 |